Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40BSP | ISIN: US29290D1173 | Ticker-Symbol:
1-Jahres-Chart  (nicht börsennotiert)
ENDO INC Chart 1 Jahr

Aktuelle News zur ENDO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoEndo maps out Men's Health Month awareness, education drive3
MoEndo, Inc.: Endo Champions Men's Health Month with Education, Awareness, and Outreach190MALVERN, Pa., June 2, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today its Men's Health Month initiative, reaffirming its commitment to advancing men's health and addressing...
► Artikel lesen
27.05.Indivior nabs Sanofi, Endo alum as chief commercial officer9
15.05.Endo, Inc.: Endo Expands ADRENALIN Ready-to-Use Premixed Bag Line with New Concentration268Endo's products are the first FDA-approved and currently the only commercially available manufacturer-prepared epinephrine premixed intravenous (IV) bag MALVERN, Pa., May 15, 2025 /PRNewswire/...
► Artikel lesen
13.05.Mallinckrodt plc: Mallinckrodt and Endo Announce Significant Progress in Proposed Merger112S-4 Registration Statement Effective; HSR Waiting Period ExpiredIrish High Court Approves Convening of Shareholder Meetings Shareholder Vote Scheduled for June 13 DUBLIN and MALVERN, Pa....
► Artikel lesen
12.05.Endo, Inc. - 10-Q, Quarterly Report1
ENDO Aktie jetzt für 0€ handeln
07.05.Endo International misses top-line estimates; reaffirms FY25 outlook1
07.05.Endo, Inc. - 8-K, Current Report2
07.05.Endo, Inc.: Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance241XIAFLEX® revenues grew 7% compared to first-quarter 2024The Company reaffirms 2025 revenue guidance of $1,775 to $1,860 million and adjusted EBITDA guidance of $620 to $650 millionCombination...
► Artikel lesen
24.04.Endo, Inc.: Endo's New Spatial Computing Injection Simulator for Peyronie's Disease Creates Immersive Learning Environment for Urology Specialists234Endo Will Launch the Simulator at the American Urological Association (AUA) Annual Meeting MALVERN, Pa., April 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch...
► Artikel lesen
23.04.Endo, Inc. - 8-K, Current Report2
07.04.Endo, Inc.: Endo to Report First Quarter 2025 Financial Results on May 7, 2025303MALVERN, Pa., April 7, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report first quarter 2025 financial results on May 7, 2025, prior...
► Artikel lesen
07.04.BWS Financial sets Endo Pharma stock Buy rating, $40 target2
04.04.Endo, Inc. - 8-K, Current Report2
24.03.Endo, Inc.: Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress601MALVERN, Pa., March 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment...
► Artikel lesen
13.03.Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger6
13.03.Pharma Giants Mallinckrodt and Endo to Merge in Multi-Billion-Dollar Deal4
13.03.Mallinckrodt and Endo sign $6.7bn merger deal2
13.03.Mallinckrodt, Endo Merger To Create Pharma Entity Valued At $7 Billion1
13.03.Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal1
Weiter >>
78 Nachrichten in den letzten 12 Monaten